The Septin9-Test Epi proColon for Laboratories

With the Septin9 test, Epi proColon, you have the opportunity to expand your service offerings with a modern, innovative and reliable alternative for colorectal cancer early detection.

To perform the innovative test, a 10 ml blood sample is adequate to generate sufficient plasma for the analysis.

The blood draw can be done at any time as there are no dietary restrictions or alterations in medication for the patient as compared to stool-based tests. Furthermore, the patient is not responsible for sampling and shipping.

Altogether the Septin9 test is comfortable and safe making it easier for the patient to participate in potentially life-saving colorectal cancer early detection.